Philip Low
Impact in
- Sensory Systems top 5%
- Ion Channels and Receptors
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Peripheral Neuropathies and Disorders
Papers in
-
- Parkinson's Disease Mechanisms and Treatments 4
- Peripheral Neuropathies and Disorders 2
- Surgery 2
- Co-authors
- Anthony J. Windebank (3 shared papers)Lauren E. Ta (3 shared papers)Charles L. Loprinzi (2 shared papers)Allan J. Bieber (2 shared papers)Susan M. Carlton (1 shared paper)Caroline Selai (3 shared papers)Niall Quinn (3 shared papers)Anette Schrag (3 shared papers)
- Journals
- Movement Disorders (2 papers)Molecular Pain (2 papers)Muscle & Nerve (2 papers)Parkinsonism & Related Disorders (1 paper)Hand (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Philip Low
11 papers receiving 574 citations
Peers
Comparison fields: 5 of 67
- Sensory Systems 63
- Neurology 177
- Physiology 176
- Oncology 170
- Pharmacology 44
Countries citing papers authored by Philip Low
This map shows the geographic impact of Philip Low's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Low with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Low more than expected).
Fields of papers citing papers by Philip Low
This network shows the impact of papers produced by Philip Low. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Low. The network helps show where Philip Low may publish in the future.
Co-authors
The 25 scholars most cited alongside Philip Low, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 163 | |
| 2 | 2009 | 128 | |
| 3 | 2010 | 101 | |
| 4 | 2013 | 48 | |
| 5 | 2007 | 40 | |
| 6 | 2001 | 40 | |
| 7 | 2015 | 22 | |
| 8 | 2015 | 19 | |
| 9 | 2004 | 17 | |
| 10 | 2012 | 5 | |
| 11 | 2019 | 5 | |
| 12 | 2001 | 0 |
About Philip Low
Philip Low is a scholar working on Neurology, Surgery, Cellular and Molecular Neuroscience, Cognitive Neuroscience and Oncology, having authored 12 papers that have together received 588 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (4 papers), Peripheral Neuropathies and Disorders (2 papers), Hereditary Neurological Disorders (2 papers), Autism Spectrum Disorder Research (1 paper), Circadian rhythm and melatonin (1 paper), Cardiovascular and exercise physiology (1 paper), PARP inhibition in cancer therapy (1 paper) and Neurogenetic and Muscular Disorders Research (1 paper). The work is most often cited by research in Sensory Systems (63 citations), Neurology (177 citations), Physiology (176 citations), Oncology (170 citations) and Pharmacology (44 citations). Philip Low has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Anthony J. Windebank, Lauren E. Ta, Charles L. Loprinzi, Allan J. Bieber, Susan M. Carlton, Caroline Selai, Niall Quinn, Anette Schrag, C.J. Mathias and James H. Bower. Their work appears in journals such as Movement Disorders, Molecular Pain, Muscle & Nerve, Parkinsonism & Related Disorders and Hand.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.